PharmaCielo Ltd.
PCLOF
$0.0478
-$0.0067-12.29%
09/30/2024 | 06/30/2024 | ||||
---|---|---|---|---|---|
Revenue | 70.12% | 221.38% | |||
Total Other Revenue | -- | -- | |||
Total Revenue | 70.12% | 221.38% | |||
Cost of Revenue | 88.71% | -21.51% | |||
Gross Profit | 35.76% | 167.93% | |||
SG&A Expenses | -35.10% | 50.43% | |||
Depreciation & Amortization | -5.68% | -46.76% | |||
Other Operating Expenses | -65.63% | -788.89% | |||
Total Operating Expenses | -9.62% | 21.70% | |||
Operating Income | 47.27% | 5.91% | |||
Income Before Tax | -2.99% | -4.84% | |||
Income Tax Expenses | -- | -- | |||
Earnings from Continuing Operations | -2.99% | -4.84% | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | -- | -- | |||
Net Income | -2.99% | -4.84% | |||
EBIT | 47.27% | 5.91% | |||
EBITDA | 48.03% | 3.57% | |||
EPS Basic | -8.11% | -4.72% | |||
Normalized Basic EPS | 24.64% | -1.47% | |||
EPS Diluted | -8.11% | -4.72% | |||
Normalized Diluted EPS | 24.64% | -1.47% | |||
Average Basic Shares Outstanding | -4.55% | 0.27% | |||
Average Diluted Shares Outstanding | -4.55% | 0.27% | |||
Dividend Per Share | -- | -- | |||
Payout Ratio | -- | -- |